DEPUY ASR XL FEM IMP SIZE 45
Report
- Report Number
- 1818910-2013-18337
- Event Type
- Injury
- Date Received
- June 6, 2013
- Date of Event
- January 24, 2014
- Report Date
- January 24, 2014
- Manufacturer
- DEPUY INTERNATIONAL LTD.
- Product Code
- KXA
- Removal / Correction Number
- Z-1749/1816-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PATIENT
Narratives
NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED.
ASR REVISION. ASR XL - UNKNOWN WHICH SIDE HIP. REASON(S) FOR REVISION: PAIN. IMPLANT TOOK PLACE IN 2006, NO SPECIFIC DATE GIVEN. UPDATE RECEIVED: (B)(6) 2014 - ADDED IMPLANT DATE: (B)(6) 2007, ADDED SURGEON: (B)(6). LEFT, ADDED FURTHER REASON(S) FOR REVISION: METALLOSIS AND HIGH METAL ION LEVEL IN BLOOD AND ADDED PRODUCTS: STEM AND TAPER SLEEVE.
ASR REVISION; ASR XL - UNKNOWN WHICH SIDE HIP; REASON(S) FOR REVISION: PAIN; IMPLANT TOOK PLACE IN 2006, NO SPECIFIC DATE GIVEN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 249808 | DEPUY ASR XL FEM IMP SIZE 45 | HIP FEMORAL HEAD | KXA | DEPUY INTERNATIONAL LTD. | 2205575 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Required Intervention |